Author: Rowlands, Marianna; Segal, Florencia; Hartl, Dominik
Title: Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19 Cord-id: v2r7dw1o Document date: 2021_6_18
ID: v2r7dw1o
Snippet: Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that govern the pathophysiology of different disease courses remain poorly defined. Across the spectrum of disease severity, COVID-19 impairs both innate and adaptive host immune responses by activating innate immune cell recruitment, while resulting in low lymphocyte counts. Recently, several reports have shown that patients with severe COVID-19 exhibit a dysregulated myeloid cell compartment, with increased myel
Document: Clinical presentations of COVID-19 are highly variable, yet the precise mechanisms that govern the pathophysiology of different disease courses remain poorly defined. Across the spectrum of disease severity, COVID-19 impairs both innate and adaptive host immune responses by activating innate immune cell recruitment, while resulting in low lymphocyte counts. Recently, several reports have shown that patients with severe COVID-19 exhibit a dysregulated myeloid cell compartment, with increased myeloid-derived suppressor cells (MDSCs) correlating with disease severity. MDSCs, in turn, promote virus survival by suppressing T-cell responses and driving a highly pro-inflammatory state through the secretion of various mediators of immune activation. Here, we summarize the evidence on MDSCs and myeloid cell dysregulation in COVID-19 infection and discuss the potential of MDSCs as biomarkers and therapeutic targets in COVID-19 pneumonia and associated disease.
Search related documents:
Co phrase search for related documents- act virus elimination and acute respiratory: 1
- act virus elimination and acute viral infection: 1
- act virus elimination and adaptive innate: 1
- activation lung infiltration and acute respiratory: 1, 2, 3
- activation lung infiltration and acute respiratory distress syndrome: 1, 2
- activator transducer and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- activator transducer and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12
- activator transducer and adaptive immune response: 1, 2, 3, 4
- activator transducer and adaptive immune system: 1
- activator transducer and adaptive innate: 1, 2, 3, 4
- active infection and acute patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
- active infection and acute respiratory: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- active infection and acute respiratory distress syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- active infection and acute viral infection: 1, 2, 3, 4, 5
- active infection and adaptive immune response: 1, 2, 3, 4, 5
- active infection and adaptive immune system: 1
- active infection and adaptive innate: 1, 2, 3, 4, 5
- acute respiratory and adaptive immune system innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- acute respiratory and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
Co phrase search for related documents, hyperlinks ordered by date